-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D1qmYCg3kw65GmUkylfCmLRoM7f4MISY3x/li9ylTyz/P+uJyUG9A9c8TBQ3J3gg xWZYppMxFhcu5noDc7hShQ== 0001029869-98-000303.txt : 19980220 0001029869-98-000303.hdr.sgml : 19980220 ACCESSION NUMBER: 0001029869-98-000303 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980219 SROS: NONE GROUP MEMBERS: BIOTECHNOLOGY INVESTMENT GROUP L L C ET AL GROUP MEMBERS: COLLINSON HOWE VENTURE PARTNERS INC. GROUP MEMBERS: EDWARD BLECH TRUST GROUP MEMBERS: JEFFREY J. COLLINSON GROUP MEMBERS: SCHRODER VENTURES LIMITED PARTNERSHIP GROUP MEMBERS: SCHRODER VENTURES U.S. TRUST GROUP MEMBERS: SCHRODERS INCORPORATED SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CELL THERAPEUTICS INC CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-48459 FILM NUMBER: 98545494 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVE W STREET 2: STE 400 CITY: SEATTLE STATE: WA ZIP: 98119 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BIOTECHNOLOGY INVESTMENT GROUP L L C ET AL CENTRAL INDEX KEY: 0000937793 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 061415704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1055 WASHINGTON BOULEVARD STREET 2: C/O COLLINSON HOWE VENTURE PARTNERS INC CITY: STAMFORD STATE: CT ZIP: 06901 BUSINESS PHONE: 2033247700 MAIL ADDRESS: STREET 1: 1055 WASHINGTON BLVD STREET 2: C/O COLLINSON HOWE VENTURE PARTNERS INC CITY: STAMFORD STATE: CT ZIP: 06901 SC 13G/A 1 ------------------------------- | OMB APPROVAL | | -------------------------- | | OMB Number: 3235-0145 | | Expires: December 31, 1997 | | Estimated avereage burden | | hours per response...14.90 | ------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Cell Therapeutics, Inc. ------------------------------------------- (Name of Issuer) Common Stock, no par value) ------------------------------------------- (Title of Class of Securities) 0001509341 ------------------------ (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - ------------------------- --------------------------- |CUSIP NO. 0001509341 | 13G | Page 2 of 13 Pages | | ---------- | | --- --- | - ------------------------- --------------------------- |--------|---------------------------------------------------------------------| | 1 | NAME OF REPORTING PERSON | | | S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON | | | BIOTECHNOLOGY INVESTMENT GROUP, LLC ("BIO") | | | 06-141 5704 | |--------|---------------------------------------------------------------------| | 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] | | | (b) [ ] | | | | |--------|---------------------------------------------------------------------| | 3 | SEC USE ONLY | | | | |--------|---------------------------------------------------------------------| | 4 | CITIZENSHIP OR PLACE OF ORGANIZATION | | | | | | Delaware | |-----------------|--------|---------------------------------------------------| | | 5 | SOLE VOTING POWER | | | | 715,755 | | NUMBER OF |--------|---------------------------------------------------| | SHARES | 6 | SHARED VOTING POWER | | BENEFICIALLY | | -0- | | OWNED BY |--------|---------------------------------------------------| | EACH | 7 | SOLE DISPOSITIVE POWER | | REPORTING | | 715,755 | | PERSON |--------|---------------------------------------------------| | WITH | 8 | SHARED DISPOSITIVE POWER | | | | -0- | |------------------------------------------------------------------------------| | 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | | | | | | 715,755 | |--------|---------------------------------------------------------------------| | 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN [ ] | | | SHARES* | | | | |--------|---------------------------------------------------------------------| | 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | | | 4.6% | |--------|---------------------------------------------------------------------| | 12 | TYPE OF REPORTING PERSON* | | | 00 | - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! - ------------------------- --------------------------- |CUSIP NO. 0001509341 | 13G | Page 3 of 13 Pages | | ---------- | | --- --- | - ------------------------- --------------------------- |--------|---------------------------------------------------------------------| | 1 | NAME OF REPORTING PERSON | | | S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON | | | EDWARD BLECH TRUST ("EBT") | | | 25-638 1634 | |--------|---------------------------------------------------------------------| | 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] | | | (b) [ ] | | | | |--------|---------------------------------------------------------------------| | 3 | SEC USE ONLY | | | | |--------|---------------------------------------------------------------------| | 4 | CITIZENSHIP OR PLACE OF ORGANIZATION | | | | | | New York | |-----------------|--------|---------------------------------------------------| | | 5 | SOLE VOTING POWER | | | | -0- | | NUMBER OF |--------|---------------------------------------------------| | SHARES | 6 | SHARED VOTING POWER | | BENEFICIALLY | | 715,755 | | OWNED BY |--------|---------------------------------------------------| | EACH | 7 | SOLE DISPOSITIVE POWER | | REPORTING | | -0- | | PERSON |--------|---------------------------------------------------| | WITH | 8 | SHARED DISPOSITIVE POWER | | | | 715,755 | |------------------------------------------------------------------------------| | 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | | | | | | 715,755 | |--------|---------------------------------------------------------------------| | 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN [ ] | | | SHARES* | | | | |--------|---------------------------------------------------------------------| | 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | | | 4.6% | |--------|---------------------------------------------------------------------| | 12 | TYPE OF REPORTING PERSON* | | | 00 | - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! - ------------------------- --------------------------- |CUSIP NO. 0001509341 | 13G | Page 4 of 13 Pages | | ---------- | | --- --- | - ------------------------- --------------------------- |--------|---------------------------------------------------------------------| | 1 | NAME OF REPORTING PERSON | | | S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON | | | COLLINSON HOWE VENTURE PARTNERS, INC. | | | 13-354 8019 | |--------|---------------------------------------------------------------------| | 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] | | | (b) [ ] | | | | |--------|---------------------------------------------------------------------| | 3 | SEC USE ONLY | | | | |--------|---------------------------------------------------------------------| | 4 | CITIZENSHIP OR PLACE OF ORGANIZATION | | | | | | Delaware | |-----------------|--------|---------------------------------------------------| | | 5 | SOLE VOTING POWER | | | | -0- | | NUMBER OF |--------|---------------------------------------------------| | SHARES | 6 | SHARED VOTING POWER | | BENEFICIALLY | | 765,061 | | OWNED BY |--------|---------------------------------------------------| | EACH | 7 | SOLE DISPOSITIVE POWER | | REPORTING | | -0- | | PERSON |--------|---------------------------------------------------| | WITH | 8 | SHARED DISPOSITIVE POWER | | | | 765,061 | |------------------------------------------------------------------------------| | 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | | | | | | 765,061 | |--------|---------------------------------------------------------------------| | 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN [ ] | | | SHARES* | | | | |--------|---------------------------------------------------------------------| | 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | | | 4.9% | |--------|---------------------------------------------------------------------| | 12 | TYPE OF REPORTING PERSON* | | | CO | - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! - ------------------------- --------------------------- |CUSIP NO. 0001509341 | 13G | Page 5 of 13 Pages | | ---------- | | --- --- | - ------------------------- --------------------------- |--------|---------------------------------------------------------------------| | 1 | NAME OF REPORTING PERSON | | | S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON | | | SCHRODERS INCORPORATED ("SI") | | | 13-262 1402 | |--------|---------------------------------------------------------------------| | 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] | | | (b) [ ] | | | | |--------|---------------------------------------------------------------------| | 3 | SEC USE ONLY | | | | |--------|---------------------------------------------------------------------| | 4 | CITIZENSHIP OR PLACE OF ORGANIZATION | | | | | | Delaware | |-----------------|--------|---------------------------------------------------| | | 5 | SOLE VOTING POWER | | | | -0- | | NUMBER OF |--------|---------------------------------------------------| | SHARES | 6 | SHARED VOTING POWER | | BENEFICIALLY | | 39,020 | | OWNED BY |--------|---------------------------------------------------| | EACH | 7 | SOLE DISPOSITIVE POWER | | REPORTING | | -0- | | PERSON |--------|---------------------------------------------------| | WITH | 8 | SHARED DISPOSITIVE POWER | | | | 39,020 | |------------------------------------------------------------------------------| | 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | | | | | | 39,020 | |--------|---------------------------------------------------------------------| | 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN [ ] | | | SHARES* | | | | |--------|---------------------------------------------------------------------| | 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | | | .003% | |--------|---------------------------------------------------------------------| | 12 | TYPE OF REPORTING PERSON* | | | CO | - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! - ------------------------- --------------------------- |CUSIP NO. 0001509341 | 13G | Page 6 of 13 Pages | | ---------- | | --- --- | - ------------------------- --------------------------- |--------|---------------------------------------------------------------------| | 1 | NAME OF REPORTING PERSON | | | S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON | | | JEFFREY J. COLLINSON ("JJC") | | | N/A | |--------|---------------------------------------------------------------------| | 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] | | | (b) [ ] | | | | |--------|---------------------------------------------------------------------| | 3 | SEC USE ONLY | | | | |--------|---------------------------------------------------------------------| | 4 | CITIZENSHIP OR PLACE OF ORGANIZATION | | | | | | U.S.A. | |-----------------|--------|---------------------------------------------------| | | 5 | SOLE VOTING POWER | | | | 5,325 | | NUMBER OF |--------|---------------------------------------------------| | SHARES | 6 | SHARED VOTING POWER | | BENEFICIALLY | | 765,061 | | OWNED BY |--------|---------------------------------------------------| | EACH | 7 | SOLE DISPOSITIVE POWER | | REPORTING | | 5,325 | | PERSON |--------|---------------------------------------------------| | WITH | 8 | SHARED DISPOSITIVE POWER | | | | 765,061 | |------------------------------------------------------------------------------| | 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | | | | | | 770,386 | |--------|---------------------------------------------------------------------| | 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN [ ] | | | SHARES* | | | | |--------|---------------------------------------------------------------------| | 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | | | 5% | |--------|---------------------------------------------------------------------| | 12 | TYPE OF REPORTING PERSON* | | | IN | - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! - ------------------------- --------------------------- |CUSIP NO. 0001509341 | 13G | Page 7 of 13 Pages | | ---------- | | --- --- | - ------------------------- --------------------------- |--------|---------------------------------------------------------------------| | 1 | NAME OF REPORTING PERSON | | | S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON | | | SCHRODER VENTURES U.S. TRUST ("SVUST") | | | 13-691 3552 | |--------|---------------------------------------------------------------------| | 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] | | | (b) [ ] | | | | |--------|---------------------------------------------------------------------| | 3 | SEC USE ONLY | | | | |--------|---------------------------------------------------------------------| | 4 | CITIZENSHIP OR PLACE OF ORGANIZATION | | | | | | Bermuda | |-----------------|--------|---------------------------------------------------| | | 5 | SOLE VOTING POWER | | | | -0- | | NUMBER OF |--------|---------------------------------------------------| | SHARES | 6 | SHARED VOTING POWER | | BENEFICIALLY | | 2,057 | | OWNED BY |--------|---------------------------------------------------| | EACH | 7 | SOLE DISPOSITIVE POWER | | REPORTING | | -0- | | PERSON |--------|---------------------------------------------------| | WITH | 8 | SHARED DISPOSITIVE POWER | | | | 2,057 | |------------------------------------------------------------------------------| | 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | | | | | | 2,057 | |--------|---------------------------------------------------------------------| | 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN [ ] | | | SHARES* | | | | |--------|---------------------------------------------------------------------| | 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | | | 0% | |--------|---------------------------------------------------------------------| | 12 | TYPE OF REPORTING PERSON* | | | 00 | - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! - ------------------------- --------------------------- |CUSIP NO. 0001509341 | 13G | Page 8 of 13 Pages | | ---------- | | --- --- | - ------------------------- --------------------------- |--------|---------------------------------------------------------------------| | 1 | NAME OF REPORTING PERSON | | | S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON | | | SCHRODER VENTURES LIMITED PARTNERSHIP ("SVLP") | | | 13-348 4238 | |--------|---------------------------------------------------------------------| | 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] | | | (b) [ ] | | | | |--------|---------------------------------------------------------------------| | 3 | SEC USE ONLY | | | | |--------|---------------------------------------------------------------------| | 4 | CITIZENSHIP OR PLACE OF ORGANIZATION | | | | | | Delaware | |-----------------|--------|---------------------------------------------------| | | 5 | SOLE VOTING POWER | | | | -0- | | NUMBER OF |--------|---------------------------------------------------| | SHARES | 6 | SHARED VOTING POWER | | BENEFICIALLY | | 8,229 | | OWNED BY |--------|---------------------------------------------------| | EACH | 7 | SOLE DISPOSITIVE POWER | | REPORTING | | -0- | | PERSON |--------|---------------------------------------------------| | WITH | 8 | SHARED DISPOSITIVE POWER | | | | 8,229 | |------------------------------------------------------------------------------| | 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | | | | | | 8,229 | |--------|---------------------------------------------------------------------| | 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN [ ] | | | SHARES* | | | | |--------|---------------------------------------------------------------------| | 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | | | .001% | |--------|---------------------------------------------------------------------| | 12 | TYPE OF REPORTING PERSON* | | | PN | - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! - ------------------------- --------------------------- |CUSIP NO. 0001509341 | 13G | Page 9 of 13 Pages | | ---------- | | --- --- | - ------------------------- --------------------------- Item 1(a). Name of Issuer: Cell Therapeutics, Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 201 Elliott Avenue West, Suite 400 Seattle, WA 98119 Item 2. Names, Addresses and Citizenship of Persons Filing: -------------------------------------------------- I. For Reporting Person -------------------- Biotechnology Investment Group, L.L.C.: a) Biotechnology Investment Group, L.L.C. b) c/o Collinson Howe Venture Partners, Inc. 1055 Washington Boulevard Stamford, CT 06901 c) Place of organization -- Delaware II. Regarding Reporting Person Edward Blech Trust: a) Edward Blech Trust b) 418 Avenue I Brooklyn, NY 11231 c) Trusted created under laws of New York Regarding Reporting Person Collinson Howe Venture Partners, Inc. a) Collinson Howe Venture Partners, Inc. b) 1055 Washington Boulevard Stamford, CT 06901 c) Place of Organization - Delaware Regarding Reporting Person: a) Schroders Incorporated b) 787 Seventh Avenue, 29th Floor New York, NY 10019 c) Place of Organization -- Delaware - ------------------------- --------------------------- |CUSIP NO. 0001509341 | 13G | Page 10 of 13 Pages | | ---------- | | --- --- | - ------------------------- --------------------------- Regarding Reporting Person Jeffrey J. Collinson: a) Jeffrey J. Collinson b) 1055 Washington Boulevard, Stamford, CT 06901 c) Citizenship - United States Regarding Reporting Person Schroder Ventures US Trust: a) Schroder Ventures U.S. Trust b) c/o Schroder Venture Managers Limited 22 Church Street Hamilton HM 11, Bermuda c) SVUST is a closed-end unit trust created under the laws of Bermuda Regarding Reporting Person Schroder Ventures Limited Partnership: a) Schroder Ventures Limited Partnership b) c/o Schroder Ventures Management L.P. 787 Seventh Avenue 29th Floor New York, NY 10019 c) Place of organization -- Delaware Item 2(d). Title of Class of Securities: Common Stock Item 2(e). CUSIP Number: 0001509341 Item 3. If this statement if filed pursuant to Rules 13d-1(b), or --------------------------------------------------------- 13d-2(b), check whether the person filing is a: ---------------------------------------------- (a) [ ] Broker or Dealer registered under Section 15 of the Securities Exchange Act of 1934 (the "Act"), (b) [ ] Bank as defined in Section 3(a)(6) of the Act, (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act, (d) [ ] Investment Company registered under Section 8 of the Investment Company Act of 1940, - ------------------------- --------------------------- |CUSIP NO. 0001509341 | 13G | Page 11 of 13 Pages | | ---------- | | --- --- | - ------------------------- --------------------------- (e) [ ] Investment Advisor registered under Section 203 of the Investment Advisers Act of 1940, (f) [ ] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see Rule 13d-1(b)(1)(ii)(f) of the Act, (g) [ ] Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G) of the Act; see Item 7, (h) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(H) of the Act. Not Applicable. Item 4. Ownership. --------- See Items 5-8 on cover pages. Item 5. Ownership of Five Percent or Less of a Class. -------------------------------------------- This statement is being filed to report the fact that as of the date hereof, the following reporting persons have ceased to be the beneficial owners of more than five percent of the class of securities: Biotechnology Investment Group, LLC Edward Blech Trust Collinson Howe Venture Partners, Inc. Schroders Incorporated Schroder Ventures U.S. Trust Schroder Ventures Limited Partnership Item 6. Ownership of More than Five Percent on Behalf of Another -------------------------------------------------------- Person ------ Not Applicable. Item 7. Identification and Classification of the Subsidiary which --------------------------------------------------------- Acquired the Security Being Reported on By the Parent Holding ------------------------------------------------------------- Company. ------- Not Applicable. Item 8. Identification and Classification of Members of the Group. --------------------------------------------------------- Not applicable. Item 9. Notice of Dissolution of Group. ------------------------------ Not Applicable. Item 10. Certification. ------------- Not Applicable. This statement on Schedule 13G is not filed pursuant to Rule 13d-1(b). - ------------------------- --------------------------- |CUSIP NO. 0001509341 | 13G | Page 12 of 13 Pages | | ---------- | | --- --- | - ------------------------- --------------------------- Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 14, 1998 BIOTECHNOLOGY INVESTMENT GROUP, L.L.C. ----------------- By: COLLINSON HOWE VENTURE PARTNERS, INC. Date Its: Managing Member By: * ------------------------------------ Jeffrey J. Collinson, President EDWARD BLECH TRUST By: * ------------------------------------ Mordechai Jofen, as Sole Trustee COLLINSON HOWE VENTURE PARTNERS, INC. By: * ------------------------------------ Jeffrey J. Collinson, President * ----------------------------------------- Jeffrey J. Collinson SCHRODERS INCORPORATED By: * ------------------------------------ Jeffrey J. Collinson, Its Attorney-in-Fact SCHRODER VENTURES U.S. TRUST By: SCHRODER VENTURE MANAGERS LIMITED Its: Manager By: * ------------------------------------ - ------------------------- --------------------------- |CUSIP NO. 0001509341 | 13G | Page 13 of 13 Pages | | ---------- | | --- --- | - ------------------------- --------------------------- SCHRODER VENTURES LIMITED PARTNERSHIP By: SCHRODER VENTURES MANAGEMENT L.P. Its: General Partner By: SCHRODER VENTURE MANAGERS INC. Its: General Partner By: * ---------------------------------------- * By: /s/Timothy C. Maguire ---------------------------------------- Timothy C. Maguire, Attorney-in-Fact -----END PRIVACY-ENHANCED MESSAGE-----